79 related articles for article (PubMed ID: 7542629)
1. Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells.
Cerutti A; Kim EC; Shah S; Schattner EJ; Zan H; Schaffer A; Casali P
Nat Immunol; 2001 Feb; 2(2):150-6. PubMed ID: 11175813
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PI3K p110δ activity reduces IgE production in IL-4 and anti-CD40 stimulated human B cell cultures.
Cutrina-Pons A; De Sa A; Fear DJ; Gould HJ; Ramadani F
Immunology; 2023 Dec; 170(4):483-494. PubMed ID: 37530226
[TBL] [Abstract][Full Text] [Related]
3. CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.
Hermiston ML; Zikherman J; Zhu JW
Immunol Rev; 2009 Mar; 228(1):288-311. PubMed ID: 19290935
[TBL] [Abstract][Full Text] [Related]
4. Upregulated Expression of the IL-9 Receptor on TRAF3-Deficient B Lymphocytes Confers Ig Isotype Switching Responsiveness to IL-9 in the Presence of Antigen Receptor Engagement and IL-4.
Gokhale S; Victor E; Tsai J; Spirollari E; Matracz B; Takatsuka S; Jung J; Kitamura D; Xie P
J Immunol; 2023 Apr; 210(8):1059-1073. PubMed ID: 36883978
[TBL] [Abstract][Full Text] [Related]
5. Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity.
Yu X; Chan HTC; Fisher H; Penfold CA; Kim J; Inzhelevskaya T; Mockridge CI; French RR; Duriez PJ; Douglas LR; English V; Verbeek JS; White AL; Tews I; Glennie MJ; Cragg MS
Cancer Cell; 2020 Jun; 37(6):850-866.e7. PubMed ID: 32442402
[TBL] [Abstract][Full Text] [Related]
6. Local Immunoglobulin E in nasal polyps: Role and modulation.
Shen Y; Zhang N; Yang Y; Hong S; Bachert C
Front Immunol; 2022; 13():961503. PubMed ID: 36159836
[TBL] [Abstract][Full Text] [Related]
7. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase.
Tan J; Town T; Mori T; Wu Y; Saxe M; Crawford F; Mullan M
J Neurosci; 2000 Oct; 20(20):7587-94. PubMed ID: 11027218
[TBL] [Abstract][Full Text] [Related]
8. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking.
Scheipers P; Reiser H
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10083-8. PubMed ID: 9707604
[TBL] [Abstract][Full Text] [Related]
9. The hyper-IgM (HIM) syndrome.
Ramesh N; Seki M; Notarangelo LD; Geha RS
Springer Semin Immunopathol; 1998; 19(4):383-99. PubMed ID: 9618764
[No Abstract] [Full Text] [Related]
10. Characterization of a 23-kDa protein associated with CD40.
Morio T; Hanissian S; Geha RS
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11633-6. PubMed ID: 8524818
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of inhibition of IgE synthesis by nedocromil sodium: nedocromil sodium inhibits deletional switch recombination in human B cells.
Loh RK; Jabara HH; Geha RS
J Allergy Clin Immunol; 1996 May; 97(5):1141-50. PubMed ID: 8626993
[TBL] [Abstract][Full Text] [Related]
12. Expression of the CD40 ligand in T lymphocytes and induction of IgE isotype switching.
Fuleihan R; Ahern D; Geha RS
Int Arch Allergy Immunol; 1995; 107(1-3):43-4. PubMed ID: 7542098
[TBL] [Abstract][Full Text] [Related]
13. Regulation of IgE synthesis by CD23/CD21 interaction.
Bonnefoy JY; Gauchat JF; Life P; Graber P; Aubry JP; Lecoanet-Henchoz S
Int Arch Allergy Immunol; 1995; 107(1-3):40-2. PubMed ID: 7542093
[TBL] [Abstract][Full Text] [Related]
14. Role of protein tyrosine kinases and phosphatases in isotype switching: crosslinking CD45 to CD40 inhibits IgE isotype switching in human B cells.
Loh RK; Jabara HH; Ren CL; Fu SM; Vercelli D; Geha RS
Immunol Lett; 1995 Feb; 45(1-2):99-106. PubMed ID: 7542629
[TBL] [Abstract][Full Text] [Related]
15. Role of protein tyrosine kinases in CD40/interleukin-4-mediated isotype switching to IgE.
Loh RK; Jabara HH; Ren CL; Fu SM; Geha RS
J Allergy Clin Immunol; 1994 Oct; 94(4):784-92. PubMed ID: 7523475
[TBL] [Abstract][Full Text] [Related]
16. Disodium cromoglycate inhibits S mu-->S epsilon deletional switch recombination and IgE synthesis in human B cells.
Loh RK; Jabara HH; Geha RS
J Exp Med; 1994 Aug; 180(2):663-71. PubMed ID: 8046339
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
